Âûñîêîêà÷åñòâåííûé ðûáèé æèð Pronova Pure® 500:200 EE EU îò Pronova BioPharma Norge AS, Íîðâåãèÿ (BASF).
ðûáèé æèð èç ñàðäèí, õàìñû è ñêóìáðèè, êàïñóëà: æåëàòèí, ãëèöåðèí (àãåíò âëàãîóäåðæèâàþùèé); àëüôà òîêîôåðîëà àöåòàò, ñìåñü òîêîôåðîëîâ (àíòèîêèñëèòåëü).
Ñîäåðæàíèå â 2 êàïñóëàõ (ñóòî÷íîì ïðèåìå) è % îò àäåêâàòíîãî óðîâíÿ ñóòî÷íîãî ïîòðåáëåíèÿ: | ||
ÏÍÆÊ îìåãà-3, íå ìåíåå, â òîì ÷èñëå: | 1400 ìã | 70% |
ýéêîçàïåíòàåíîâàÿ êèñëîòà (ÝÏÊ), íå ìåíåå | 760 ìã | 126% |
äîêîçàãåêñàåíîâàÿ êèñëîòà (ÄÃÊ), íå ìåíåå | 380 ìã | 54% |
Âèòàìèí Å, íå ìåíåå | 1,5 ìã ÒÝ | 15% |
Ïèùåâàÿ öåííîñòü 2 êàïñóë (ñóòî÷íûé ïðèåì): áåëêè – 0,4 ã, æèðû – 2,0 ã, óãëåâîäû – 0 ã, ýíåðãåòè÷åñêàÿ öåííîñòü (êàëîðèéíîñòü) – 80 êÄæ (20 êêàë).
Ðåêîìåíäàöèè ïî ïðèìåíåíèþ | Âçðîñëûì ïðèíèìàòü ïî 2 êàïñóëû 1 ðàç â äåíü âî âðåìÿ åäû. Ïðîäîëæèòåëüíîñòü ïðèåìà – 1 ìåñÿö. Ïðè íåîáõîäèìîñòè ïðèåìà ìîæíî ïîâòîðèòü. |
Ïðîòèâîïîêàçàíèÿ | Èíäèâèäóàëüíàÿ íåïåðåíîñèìîñòü êîìïîíåíòîâ, áåðåìåííîñòü, êîðìëåíèå ãðóäüþ. Ïåðåä ïðèìåíåíèåì ðåêîìåíäóåòñÿ ïðîêîíñóëüòèðîâàòüñÿ ñ âðà÷îì. |
Ñâèäåòåëüñòâî î ãîñóäàðñòâåííîé ðåãèñòðàöèè (ÑîÃÐ) | ¹ RU.77.99.88.003.E.001918.04.17 îò 20.04.2017 ã. |
Ôîðìà âûïóñêà | Êàïñóëû |
Êîëè÷åñòâî êàïñóë â óïàêîâêå | 30 ïî 1,0 ã |
Ñðîê ãîäíîñòè | 2 ãîäà |
Óñëîâèÿ õðàíåíèÿ | Õðàíèòü ïðè òåìïåðàòóðå íå âûøå 25°Ñ |
! Ïåðåä ïðèåìîì ïðåïàðàòîâ íåîáõîäèìà êîíñóëüòàöèÿ âðà÷à.
Óïàêîâêà: 700 ìã (30 êàïñóë).
Ïðîèçâîäèòåëü: Ýâàëàð.